ÌÇÐÄÆƽâ°æ

Coronavirus: the pharma and medtech response

Statistics report about the pharma and medtech response to the coronavirus pandemic

This report presents the response of the pharmaceutical and medical device industry to the COVID-19 pandemic. It is focused on some major aspects in relation to COVID-19: treatments, vaccines, diagnostics, and ventilators. There is also a chapter comparing biotechnology companies BioNTech and Moderna, the frontrunners in the race for the first coronavirus vaccine brought to market.

Download your Report

  We value your privacy and will never rent or sell your email address.

Privacy

Table of contents

Pharma - before the pandemic

6
  • Premium Statistic Pharmaceutical market size worldwide 2001-2029
  • Premium Statistic Top global pharmaceutical companies based on pharma revenue 2022
  • Premium Statistic Size of the global vaccine market by region 2014-2024
  • Basic Statistic Leading pharmaceutical companies by global vaccine revenue 2021
  • Basic Statistic Global anti-viral market size 2019 and 2027 forecast
  • Premium Statistic Leading pharmaceutical companies by global anti-viral revenue 2017 and 2024

Treatments and vaccines

9
  • Basic Statistic Biotechs: duration of COVID-19 response compared to previous health threats 2003-2019
  • Premium Statistic Number of registered COVID-19 studies worldwide Apr 2020 - Dec 2022, by region
  • Basic Statistic Number of COVID-19 drugs in development worldwide by phase June 2022
  • Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
  • Basic Statistic Number of COVID-19 treatment vaccine trials worldwide by phase June 2022
  • Basic Statistic Number of COVID-19 treatment vaccine trials worldwide by type June 2022
  • Premium Statistic Select COVID-19 vaccine pricing and funding as of August 2020
  • Basic Statistic Gilead Science's remdesivir manufacturing projections 2020
  • Premium Statistic Worldwide remdesivir sales forecast 2020-2026

Focus: BioNTech and Moderna

7
  • Basic Statistic COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020
  • Basic Statistic Revenue of BioNTech 2017-2025
  • Basic Statistic Operating income of BioNTech 2017-2024
  • Basic Statistic BioNTech total assets 2017-2025
  • Basic Statistic Moderna's revenue 2016-2025
  • Basic Statistic R&D expenses of Moderna 2016-2024
  • Basic Statistic R&D expenses of Moderna by type 2025

Opinions on COVID-19 vaccines

6
  • Basic Statistic U.S. adults who would get a coronavirus vaccine, Jan. 2020 to Jan. 2021
  • Basic Statistic U.S. adults who would hypothetically get a coronavirus vaccine as of 2020, by gender
  • Basic Statistic U.S. adults who would hypothetically get a coronavirus vaccine October 2020, by age
  • Basic Statistic Share of Canadians who would get vaccinated for COVID Jul. 2020 - Mar. 2021
  • Premium Statistic Willingness to wait before getting COVID-19 vaccine once available in Italy 2020
  • Basic Statistic Brazil: intention to get immunized against COVID-19 2021

Business impact

4
  • Basic Statistic Market capitalization change in key COVID-19 firms until end-May 2020
  • Basic Statistic Top challenges for pharmaceutical companies during COVID-19 2020
  • Basic Statistic Launch disruption on global pharmaceutical market due to coronavirus 2020-2025
  • Premium Statistic Covid-19 impact: global pharma specialty excipient demand CAGR 2019-2024

Medtech - before the pandemic

5
  • Premium Statistic Total medtech revenue worldwide 2011-2024
  • Premium Forecast In-vitro diagnostics market revenue worldwide 2016-2030
  • Basic Statistic Global in vitro diagnostics market share by top medtech companies 2017 and 2024
  • Basic Statistic Global ventilator market size 2018-2026
  • Premium Statistic Global ventilator market size by type 2018-2026

Ventilators and testing

7
  • Basic Statistic Number of COVID-19-related EUAs for ventilators developed by company May 2020
  • Basic Statistic Respiratory devices with potential being modified to ventilators by company 2020
  • Basic Statistic Weekly ventilator production change in U.S. due to COVID-19 until April 2020
  • Basic Statistic Cumulative EUAs granted to COVID-19 tests March-November 2020
  • Basic Statistic Accuracy figures for selected COVID-19 antibody tests sold in the US 2020
  • Basic Statistic Number of COVID-19 tests carried out daily in U.S. March-November2020
  • Basic Statistic Rate change of COVID-19 testing in select countries April-November 2020
Report this content
FURTHER REPORTS

Recommended and recent reports

Recommended statistics

You may also be interested in...
We’re happy to help

Get in touch with us for additional information

Feel free to contact us anytime. We will respond to your inquiry as quickly as possible.

Get in touch